Quantum Genomics (Alternext – FR0011648971 – ALQGC), a biopharmaceutical company with the mission of developing new therapies for unmet medical needs in the field of cardiovascular diseases, strengthens its organization and management team with the appointment of Dr Olivier Madonna as Chief Medical Officer of the company.
Olivier Madonna will be in charge of the clinical developments of Quantum Genomics’ drug candidates and of the relations with regulatory authorities and drug safety agencies.
He will also lead the work on patients’ stratification and products positioning.
[button link=”http://www.quantum-genomics.com/www/wp-content/uploads/2014/11/QGC_PR_Nomination-Olivier-Madonna_27112014_UK.pdf” target=”_blank” title=”Download press release” size=”small” color=”red”]